Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
8,896,104
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
324,307
-
Shares change
-
-33,922
-
Total reported value, excl. options
-
$890,421
-
Value change
-
-$93,998
-
Number of buys
-
6
-
Number of sells
-
-4
-
Price
-
$2.75
Significant Holders of BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX) as of Q4 2022
15 filings reported holding BRTX - BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value as of Q4 2022.
BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 324,307 shares
of 8,896,104 outstanding shares and own 3.65% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (135,046 shares), Wealth Alliance (44,316 shares), Ayrton Capital LLC (41,374 shares), Cambridge Investment Research Advisors, Inc. (28,050 shares), Mariner, LLC (26,668 shares), StoneX Group Inc. (18,337 shares), GEODE CAPITAL MANAGEMENT, LLC (13,698 shares), BOOTHBAY FUND MANAGEMENT, LLC (12,296 shares), Tower Research Capital LLC (TRC) (4,181 shares), and Steward Partners Investment Advisory, LLC (2,000 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.